NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis by McCormick, Matthew et al.
MEETING ABSTRACT Open Access
NFkB activation promotes immune activation in
HTLV-I-associated myelopathy / tropical spastic
paraparesis
Matthew McCormick
1, Unsong Oh
1, Dibyadeep Datta
1, Richard Turner
1, Kathryn Bobb
2, Dileep Monie
2,
Drago R Sliskovic
3, Jie Zhang
2, Jeffrey Meshulam
2, Steven Jacobson
1*
From 15th International Conference on Human Retroviruses: HTLV and Related Viruses
Leuven and Gembloux, Belgium. 5-8 June 2011
Evidence suggests that HTLV-I-induced immune activa-
tion plays a key role in the pathogenesis of HAM/TSP.
The HTLV-I-encoded transactivating protein Tax is
known to activate nuclear factor kappa B (NFkB), a key
host signaling pathway regulating immune response, but
the contribution of the NFkB pathway to the immune
activation associated with HAM/TSP has yet to be fully
defined. We examined NFkB activation in peripheral-
blood mononuclear cells (PBMC) from subjects with
HAM/TSP, and tested the effect of NFkB inhibition on
key ex vivo correlates of immune activation in HAM/
TSP.
We examined the role of NFkB activation during
immune activation associated with HAM/TSP by using
small molecule NFkB inhibitors, including a newly
developed selective inhibitor of NFkB, PBS-1086.
NFkB activation was assessed in peripheral-blood
mononuclear cells (PBMC) from subjects with HAM/
TSP and in healthy donors (HD). Nuclear translocation
of the NFkB RelA was significantly higher in PBMC
from subjects with HAM/TSP compared to HD
(p=0.032) following short-term (20 h) culture, indicating
increased activation of the NFkB pathway in HAM/TSP.
Treatment with the small molecule inhibitor PBS-1086
reduced NFkB activation (p<0.01). PBS-1086 reduced
expression of CD25 and CD69 in HAM/TSP PBMC as
well as phosphorylation of STAT5 in a dose-dependent
manner (p<0.01 for all). PBS-1086 also inhibited sponta-
neous lymphoproliferation of HAM/TSP PBMC in a
dose-dependent manner (p=0.0286). PBS-1086 treatment
resulted in a mean proviral load reduction of 20% com-
pared to untreated PBMC in a 72 h culture
These results indicate that NFkB activation plays a cri-
tical upstream role in the immune activation associated
with HAM/TSP, and identify the NFkB pathway as a
potential therapeutic target for immune modulation in
HAM/TSP.
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